Combined bupropion-levodopa-trazodone therapy of sleep-related eating and sleep disruption in two adults with chemical dependency.
Schenck
C H
CH
Mahowald
M W
MW
D000328:Adult; D018687:Antidepressive Agents, Second-Generation / Q000008:administration & dosage / Q000627:therapeutic use*; D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D016642:Bupropion / Q000008:administration & dosage / Q000627:therapeutic use*; D003865:Major Depressive Disorder / Q000150:complications / Q000188:drug therapy; D004359:Drug Therapy, Combination; D001068:Feeding and Eating Disorders / Q000150:complications* / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D019966:Substance-Related Disorders / Q000150:complications*; D014196:Trazodone / Q000008:administration & dosage / Q000627:therapeutic use*; D014851:Wakefulness / Q000502:physiology
D018687:Antidepressive Agents, Second-Generation; D000978:Antiparkinson Agents; D016642:Bupropion; D007980:Levodopa; D014196:Trazodone